Dark | Light
# $gmab

Genmab's drug Epkinly has failed its first confirmatory test, raising concerns about its efficacy. Meanwhile, new insights into the mechanisms of antibody-drug conjugates from competitors like J&J and Merck have been revealed.

### About $gmab
Genmab is a biotechnology company focused on developing and manufacturing antibody therapeutics.  

### Engagements: [---] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$gmab/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$gmab/time-series/interactions.tsv)  
Current Value: [---]  
Daily Average: [-----]  
[--] Month: [-------] +27%  
[--] Months: [---------] +63%  
[--] Year: [---------] +25%  
1-Year High: [-------] on 2025-09-29  
1-Year Low: [---] on 2025-12-14  

Engagements by network (24h):
YouTube: [--]
X: [---]
Reddit: [--]

  
  
### Mentions: [--] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$gmab/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$gmab/time-series/posts_active.tsv)  
Current Value: [--]  
Daily Average: [--]  
1-Year High: [---] on 2025-11-08  
1-Year Low: [--] on 2025-04-19  

Mentions by network (24h):
YouTube: [--]
X: [--]
Reddit: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$gmab/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$gmab/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning $gmab in the last [--] hours which is down 24% from [--] in the previous [--] hours
Daily Average: [--]  
1-Year High: [---] on 2025-11-08  
1-Year Low: [--] on 2025-04-19  

The most influential creators that mention $gmab in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@NightOwlBiotech](/creator/twitter/NightOwlBiotech) | [--]    | [-----]     | [--]     | [---]         |
| [@JacobPlieth](/creator/twitter/JacobPlieth)         | [--]    | [------]    | [--]     | [---]         |
| [@SenefLiveEvents](/creator/twitter/SenefLiveEvents) | [--]    | [-----]     | [--]     | [---]         |
| [@ChartMill](/creator/twitter/ChartMill)             | [--]    | [------]    | [--]     | [--]          |
| [@EgidiusLambrech](/creator/twitter/EgidiusLambrech) | [--]    | [---]       | [--]    | [--]          |
| [@MarcJacksonLA](/creator/twitter/MarcJacksonLA)     | [--]    | [-----]     | [--]     | [--]          |
| [@kinatsofrim](/creator/twitter/kinatsofrim)         | [--]    | [---]       | [--]     | [--]           |
| [@investseekers](/creator/twitter/investseekers)     | [--]    | [-----]     | [--]     | [--]           |

[View More](/list/creators/$gmab/100)
  
  
### Sentiment: 91%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$gmab/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$gmab/time-series/sentiment.tsv)  
Current Value: 91%  
Daily Average: 83%  
[--] Month: 81% -1%  
[--] Months: 81% +6%  
[--] Year: 81% +2%  
1-Year High: 100% on 2025-02-15  
1-Year Low: 42% on 2025-11-29  

Most Supportive Themes:
- Earnings Calendar Mentions: (33%) A list of companies with upcoming earnings reports.
- Antibody-Drug Conjugate (ADC) Mechanisms: (33%) Discussion of the mechanisms behind antibody-drug conjugates, a type of cancer therapy.
  
Most Critical Themes:
- Epkinly Trial Failure: (33%) Genmab's drug Epkinly has failed a confirmatory test.
  

### Top $gmab Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"Earnings Calendar $FN $RMBS $IDXX $PLTR $TER $TSN $LITE $AMD $AMGN $CRUS $MRK $TTWO $PFE $ADM $GOOG $GOOGL $LLY $SITM $NYT $NVS $GSK $BOOT $STE $CME $NVO $ABBV $ORLY $BE $GMAB $MPWR $RL $ILMN $CAH $NVST $ARWR $AMZN $BMY $NVT $CBOE $SPX $NYSE $NDX $IBD $IWM $XLY $IBB"  
[X Link](https://x.com/STaylor76084368/status/2017748467754365206) [@STaylor76084368](/creator/x/STaylor76084368) 2026-01-31T23:54Z [---] followers, [---] engagements


"With a tipoff from a friend and some info that probably shouldn't have been posted in a trial registry the mechanisms of ADCs JNJ-95437446 $JNJ & SKB571/ MK-2750 $MRK have been revealed. Quite amazing given the recent $GMAB news. Via @ApexOnco - https://www.oncologypipeline.com/apexonco/node/1874 https://www.oncologypipeline.com/apexonco/node/1874"  
[X Link](https://x.com/JacobPlieth/status/2016896251233534381) [@JacobPlieth](/creator/x/JacobPlieth) 2026-01-29T15:28Z 31.7K followers, [----] engagements


"$GMAB $ABBV Epkinly fails its first confirmatory test https://www.oncologypipeline.com/apexonco/epkinly-fails-its-first-confirmatory-test https://www.oncologypipeline.com/apexonco/epkinly-fails-its-first-confirmatory-test"  
[X Link](https://x.com/MarcJacksonLA/status/2013354728483160517) [@MarcJacksonLA](/creator/x/MarcJacksonLA) 2026-01-19T20:55Z [----] followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

$gmab

Genmab's drug Epkinly has failed its first confirmatory test, raising concerns about its efficacy. Meanwhile, new insights into the mechanisms of antibody-drug conjugates from competitors like J&J and Merck have been revealed.

About $gmab

Genmab is a biotechnology company focused on developing and manufacturing antibody therapeutics.

Engagements: [---] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [-----]
[--] Month: [-------] +27%
[--] Months: [---------] +63%
[--] Year: [---------] +25%
1-Year High: [-------] on 2025-09-29
1-Year Low: [---] on 2025-12-14

Engagements by network (24h): YouTube: [--] X: [---] Reddit: [--]

Mentions: [--] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
1-Year High: [---] on 2025-11-08
1-Year Low: [--] on 2025-04-19

Mentions by network (24h): YouTube: [--] X: [--] Reddit: [--]

Creators: [--] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning $gmab in the last [--] hours which is down 24% from [--] in the previous [--] hours Daily Average: [--]
1-Year High: [---] on 2025-11-08
1-Year Low: [--] on 2025-04-19

The most influential creators that mention $gmab in the last [--] hours

Creator Rank Followers Posts Engagements
@NightOwlBiotech [--] [-----] [--] [---]
@JacobPlieth [--] [------] [--] [---]
@SenefLiveEvents [--] [-----] [--] [---]
@ChartMill [--] [------] [--] [--]
@EgidiusLambrech [--] [---] [--] [--]
@MarcJacksonLA [--] [-----] [--] [--]
@kinatsofrim [--] [---] [--] [--]
@investseekers [--] [-----] [--] [--]

View More

Sentiment: 91%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 91%
Daily Average: 83%
[--] Month: 81% -1%
[--] Months: 81% +6%
[--] Year: 81% +2%
1-Year High: 100% on 2025-02-15
1-Year Low: 42% on 2025-11-29

Most Supportive Themes:

  • Earnings Calendar Mentions: (33%) A list of companies with upcoming earnings reports.
  • Antibody-Drug Conjugate (ADC) Mechanisms: (33%) Discussion of the mechanisms behind antibody-drug conjugates, a type of cancer therapy.

Most Critical Themes:

  • Epkinly Trial Failure: (33%) Genmab's drug Epkinly has failed a confirmatory test.

Top $gmab Social Posts

Top posts by engagements in the last [--] hours

Showing a maximum of [--] top social posts without a LunarCrush subscription.

"Earnings Calendar $FN $RMBS $IDXX $PLTR $TER $TSN $LITE $AMD $AMGN $CRUS $MRK $TTWO $PFE $ADM $GOOG $GOOGL $LLY $SITM $NYT $NVS $GSK $BOOT $STE $CME $NVO $ABBV $ORLY $BE $GMAB $MPWR $RL $ILMN $CAH $NVST $ARWR $AMZN $BMY $NVT $CBOE $SPX $NYSE $NDX $IBD $IWM $XLY $IBB"
X Link @STaylor76084368 2026-01-31T23:54Z [---] followers, [---] engagements

"With a tipoff from a friend and some info that probably shouldn't have been posted in a trial registry the mechanisms of ADCs JNJ-95437446 $JNJ & SKB571/ MK-2750 $MRK have been revealed. Quite amazing given the recent $GMAB news. Via @ApexOnco - https://www.oncologypipeline.com/apexonco/node/1874 https://www.oncologypipeline.com/apexonco/node/1874"
X Link @JacobPlieth 2026-01-29T15:28Z 31.7K followers, [----] engagements

"$GMAB $ABBV Epkinly fails its first confirmatory test https://www.oncologypipeline.com/apexonco/epkinly-fails-its-first-confirmatory-test https://www.oncologypipeline.com/apexonco/epkinly-fails-its-first-confirmatory-test"
X Link @MarcJacksonLA 2026-01-19T20:55Z [----] followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

$gmab
/topic/$gmab